ArticleJHEP reports : innovation in hepatology2025
Corrigendum to 'B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis' [J Hepatol (2022) doi: 10.1016/j.jhepr.2022.100460].
Maaike Biewenga et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.